WP
NGNE icon

Woodline Partners’s Neurogene NGNE Stock Holding History

Woodline Partners’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.64M Hold
83,835
– – 0.01% 805
2026
Q1 		$1.69M Hold
83,835
– – 0.01% 824
2025
Q4 		$1.73M Hold
83,835
– – 0.01% 787
2025
Q3 		$1.45M Hold
83,835
– – 0.01% 765
2025
Q2 		$1.25M Buy
83,835
+425
+0.5% +$6.67K 0.01% 783
2025
Q1 		$977K Buy
83,410
+70
+0.1% +$1.22K 0.01% 766
2024
Q4 		$1.91M Buy
83,340
+252
+0.3% +$9.38K 0.01% 659
2024
Q3 		$3.49M Buy
+83,088
New +$3.22M 0.03% 431

Other funds holding NGNE

SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Woodline Partners's NGNE Position: Q2 2026 in Review

Woodline Partners held its Neurogene (NGNE) position steady in Q2 2026 at 83,835 shares worth $2.64M. The position accounts for 0.01% of the portfolio, ranked #805.

Woodline Partners first reported a position in NGNE in Q3 2024 and has held it in 8 quarters since. The position peaked at $3.49M in Q3 2024. 112 funds tracked by Wall St. Rank hold NGNE as of Q2 2026.

  • Woodline Partners held 83,835 shares of Neurogene worth $2.64M as of Q2 2026.
  • Woodline Partners left its Neurogene share count unchanged in Q2 2026.
  • Neurogene made up 0.01% of Woodline Partners's portfolio in Q2 2026, its #805 holding.
  • Woodline Partners first reported a position in Neurogene in Q3 2024 and has held it in 8 quarters since.
  • Woodline Partners's Neurogene position peaked at $3.49M in Q3 2024.
  • 112 funds tracked by Wall St. Rank held Neurogene as of Q2 2026.

Based on Woodline Partners's 13F filing for Q2 2026, filed 14 Aug 2026.